By: Kairos Ventures On: May 1, 2023 In: Actinia, Portfolio News

Kairos Ventures is excited to announce Northwestern Professor Mercouri Kanatzidis’ election to the American Academy of Arts and Sciences!...

Read more

Axial Therapeutics announced it is expanding the age eligibility criterion to include children ages 5 to 17 years in...

Read more

Axial Therapeutics announced key promotions in its research and development organization. These promotions recognize the Axial team’s scientific and...

Read more
By: Kairos Ventures On: March 28, 2023 In: MemVerge, Portfolio News

MemVerge attends MemCon to demonstrate the capacity and performance benefits of Compute Express Link™ (CXL™) memory. The demo features a...

Read more
By: Kairos Ventures On: March 27, 2023 In: MemVerge, Portfolio News

TechArena host Allyson Klein chats with MemVerge founder and CEO Charles Fan about his company’s disruptive vision for breaking...

Read more
By: Kairos Ventures On: March 24, 2023 In: Kairos News

“The reason they target that time to sell is because [trials] are expensive, but relatively inexpensive [compared to the...

Read more
By: Kairos Ventures On: March 21, 2023 In: Portfolio News, PteroDynamics

PteroDynamics announced the appointment of Richard Brasel as its Chief Revenue Officer. Brasel brings with him a wealth of...

Read more
By: Kairos Ventures On: February 28, 2023 In: Portfolio News, PteroDynamics

PteroDynamics announced the close of a $7.5 million Seed round. The round was co-led by existing investor Kairos Ventures...

Read more

Tempus announced a brand-new multi-omics collaboration with Actuate Therapeutics to support its ongoing Phase 1/2 Study of elraglusib, formerly...

Read more
By: Kairos Ventures On: February 13, 2023 In: Kairos News

At the turn of the 21st century, scientists Robert Langreth and Michael Waldholz posited a new idea: What if...

Read more